<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:ynews="http://news.yahoo.com/rss/">
    <channel>
        <title>Nova Reader - Subject</title>
        <link>https://www.novareader.co</link>
        <description>Default RSS Feed</description>
        <language>en-us</language>
        <copyright>Newgen KnowledgeWorks</copyright>
        <item>
            <title><![CDATA[Keeping track of time: The fundamentals of cellular clocks]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766056352662-c1944435-3425-4db2-8e2d-c7356c65c1ac/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1083/jcb.202005136</link>
            <description><![CDATA[<p class="para" id="N65540">Gliech and Holland discuss the guiding design principles of biological clocks across a variety of model systems.</p><p class="para" id="N65539">Biological timekeeping enables the coordination and execution of complex cellular processes such as developmental programs, day/night organismal changes, intercellular signaling, and proliferative safeguards. While these systems are often considered separately owing to a wide variety of mechanisms, time frames, and outputs, all clocks are built by calibrating or delaying the rate of biochemical reactions and processes. In this review, we explore the common themes and core design principles of cellular clocks, giving special consideration to the challenges associated with building timers from biochemical components. We also outline how evolution has coopted time to increase the reliability of a diverse range of biological systems.</p>]]></description>
            <pubDate><![CDATA[2020-09-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Pathogenic mutations in the kinesin-3 motor KIF1A diminish force generation and movement through allosteric mechanisms]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765978712883-f54306c7-6047-42c8-a026-88e89954ac1e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1083/jcb.202004227</link>
            <description><![CDATA[<p class="para" id="N65540">Kinesin-3 motors are fast and superprocessive, but their force generation properties remain unclear. The authors show that KIF1A detaches under low opposing forces but rapidly reattaches to continue motility. Rapid reattachment depends on the class-specific K-loop, whereas mutations linked to neurodevelopmental disorders impair force generation and motility.</p><p class="para" id="N65539">The kinesin-3 motor KIF1A functions in neurons, where its fast and superprocessive motility facilitates long-distance transport, but little is known about its force-generating properties. Using optical tweezers, we demonstrate that KIF1A stalls at an opposing load of ~3 pN but more frequently detaches at lower forces. KIF1A rapidly reattaches to the microtubule to resume motion due to its class-specific K-loop, resulting in a unique clustering of force generation events. To test the importance of neck linker docking in KIF1A force generation, we introduced mutations linked to human neurodevelopmental disorders. Molecular dynamics simulations predict that V8M and Y89D mutations impair neck linker docking. Indeed, both mutations dramatically reduce the force generation of KIF1A but not the motor’s ability to rapidly reattach to the microtubule. Although both mutations relieve autoinhibition of the full-length motor, the mutant motors display decreased velocities, run lengths, and landing rates and delayed cargo transport in cells. These results advance our understanding of how mutations in KIF1A can manifest in disease.</p>]]></description>
            <pubDate><![CDATA[2021-01-26T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[EGF receptor–mediated FUS phosphorylation promotes its nuclear translocation and fibrotic signaling]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765973921329-6d50d241-4740-4c7a-8c04-cebd0c004ab8/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1083/jcb.202001120</link>
            <description><![CDATA[<p class="para" id="N65540">Chiusa et al. show that the RNA-DNA binding protein FUS plays a profibrotic role by binding to the collagen IV gene promoter and commencing its transcription. Reducing nuclear FUS inhibits collagen IV transcription, suggesting that targeting FUS offers a new antifibrotic therapy.</p><p class="para" id="N65539">Excessive accumulation of collagen leads to fibrosis. Integrin α1β1 (Itgα1β1) prevents kidney fibrosis by reducing collagen production through inhibition of the EGF receptor (EGFR) that phosphorylates cytoplasmic and nuclear proteins. To elucidate how the Itgα1β1/EGFR axis controls collagen synthesis, we analyzed the levels of nuclear tyrosine phosphorylated proteins in WT and Itgα1-null kidney cells. We show that the phosphorylation of the RNA-DNA binding protein fused in sarcoma (FUS) is higher in Itgα1-null cells. FUS contains EGFR-targeted phosphorylation sites and, in Itgα1-null cells, activated EGFR promotes FUS phosphorylation and nuclear translocation. Nuclear FUS binds to the collagen IV promoter, commencing gene transcription that is reduced by inhibiting EGFR, down-regulating FUS, or expressing FUS mutated in the EGFR-targeted phosphorylation sites. Finally, a cell-penetrating peptide that inhibits FUS nuclear translocation reduces FUS nuclear content and collagen IV transcription. Thus, EGFR-mediated FUS phosphorylation regulates FUS nuclear translocation and transcription of a major profibrotic collagen gene. Targeting FUS nuclear translocation offers a new antifibrotic therapy.</p>]]></description>
            <pubDate><![CDATA[2020-07-17T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The cell biology of inflammation: From common traits to remarkable immunological adaptations]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608261606-16dbd9ef-899c-45ef-8480-acaf8dbdf476/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1083/jcb.202004003</link>
            <description><![CDATA[<p class="para" id="N65540">Weavers and Martin revisit Metchnikoff’s classic observations of inflammatory cell behavior in damaged tissues and update them with the latest cell biology studies.</p><p class="para" id="N65539">Tissue damage triggers a rapid and robust inflammatory response in order to clear and repair a wound. Remarkably, many of the cell biology features that underlie the ability of leukocytes to home in to sites of injury and to fight infection—most of which are topics of intensive current research—were originally observed in various weird and wonderful translucent organisms over a century ago by Elie Metchnikoff, the “father of innate immunity,” who is credited with discovering phagocytes in 1882. In this review, we use Metchnikoff’s seminal lectures as a starting point to discuss the tremendous variety of cell biology features that underpin the function of these multitasking immune cells. Some of these are shared by other cell types (including aspects of motility, membrane trafficking, cell division, and death), but others are more unique features of innate immune cells, enabling them to fulfill their specialized functions, such as encapsulation of invading pathogens, cell–cell fusion in response to foreign bodies, and their self-sacrifice as occurs during NETosis.</p>]]></description>
            <pubDate><![CDATA[2020-06-15T00:00]]></pubDate>
        </item>
    </channel>
</rss>